VELXERA
VELXERA Products

Injection Peptides

Explore products, choose your size and add to your bag.

← Products
← All categories

Weight Management

Retatrutide

Availability pending confirmation

Choose size

  • Free Accessories
  • Full Consultation & Meal Plan

Comprehensive Bloodtest add on RM200

Retatrutide is a once-weekly injectable peptide designed to support significant weight management and improved metabolic health. It is a next-generation triple hormone receptor agonist targeting the GLP-1, GIP and glucagon receptors, helping to regulate appetite, improve glucose metabolism and increase energy expenditure.

Read more

By working through multiple metabolic pathways, retatrutide has shown substantial weight-loss potential in clinical studies while supporting blood sugar control and overall metabolic function. It is being developed as a potential treatment for obesity, overweight conditions with related health complications, and metabolic disorders.

Key Features

  • Once-weekly subcutaneous injection
  • Triple mechanism of action (GLP-1, GIP and glucagon receptor agonist)
  • Supports appetite control and reduced food intake
  • Promotes calorie burning and fat reduction
  • Helps improve blood glucose regulation
  • Currently in clinical development and evaluation

Note: Retatrutide remains an investigational medicine and may not be approved for routine clinical use in all countries. Its safety and effectiveness continue to be evaluated in ongoing clinical trials.

Tirzepatide

Availability pending confirmation

Choose size

  • Free Accessories
  • Full Consultation & Meal Plan

Comprehensive Bloodtest add on RM200

Tirzepatide is a once-weekly injectable medicine designed to support weight management and blood sugar control. It works as a dual GIP and GLP-1 receptor agonist, helping to regulate appetite, improve insulin sensitivity and reduce food intake.

Read more

By targeting two key metabolic hormones, tirzepatide helps individuals achieve significant weight loss while improving glucose control. It is approved in many countries for the treatment of type 2 diabetes and, in some regions, for chronic weight management under different brand names.

Key Features

  • Once-weekly subcutaneous injection
  • Dual mechanism of action (GIP and GLP-1 receptor agonist)
  • Helps reduce appetite and cravings
  • Supports sustainable weight loss
  • Improves blood sugar control
  • May contribute to better metabolic health

Benefits

  • Significant weight reduction
  • Improved glycaemic control
  • Reduced calorie intake through appetite suppression
  • Convenient weekly dosing schedule

Common Side Effects

  • Nausea
  • Diarrhoea
  • Vomiting
  • Constipation
  • Stomach discomfort

AOD-9604

Availability pending confirmation

AOD-9604 is a synthetic peptide fragment derived from the human growth hormone (HGH) molecule. It was developed to support fat metabolism and weight-management goals by targeting the pathways involved in breaking down and using stored body fat.

Read more

Unlike full growth hormone, AOD-9604 is designed to focus specifically on fat metabolism without promoting the broader growth-related effects associated with HGH. It is commonly explored in wellness and metabolic health programmes aimed at supporting improved body composition.

Key Features

  • Synthetic peptide derived from HGH fragment 176-191
  • Supports fat metabolism and lipolysis
  • Designed to target fat-loss pathways
  • Does not show the full biological activity of growth hormone
  • Commonly investigated for weight-management applications

Potential Benefits

  • Supports the breakdown of stored body fat
  • May help achieve body-composition goals
  • Complements healthy diet and exercise programmes
  • Investigated for metabolic wellness support

Cagrilintide

Availability pending confirmation

Cagrilintide is a long-acting amylin analogue peptide developed to support weight management and appetite control. It mimics the effects of amylin, a natural hormone released alongside insulin that helps regulate hunger, food intake and feelings of fullness.

Read more

By increasing satiety and reducing appetite, cagrilintide may help individuals consume fewer calories and support sustainable weight-loss efforts. It is being studied both as a standalone therapy and in combination with GLP-1 receptor agonists for enhanced weight-management outcomes.

Key Features

  • Long-acting amylin analogue
  • Supports appetite suppression and satiety
  • Helps reduce food intake
  • Once-weekly administration in clinical development
  • Investigated for chronic weight management

Potential Benefits

  • Increased fullness after meals
  • Reduced hunger and cravings
  • Support for healthy weight-loss goals
  • May complement other metabolic health therapies

Tesamorelin

Availability pending confirmation

20MG

Tesamorelin is a synthetic growth hormone-releasing hormone (GHRH) analogue designed to stimulate the body's natural growth hormone production. By increasing growth hormone release, Tesamorelin supports healthy metabolism, body composition and fat utilisation while promoting overall wellbeing and vitality.

Read more

Tesamorelin is known for its ability to help reduce visceral adipose tissue (deep abdominal fat) and support metabolic health. It has gained attention in wellness programmes focused on performance, longevity and body composition.

Key Features

  • Synthetic Growth Hormone-Releasing Hormone (GHRH) analogue
  • Stimulates natural growth hormone production
  • Supports healthy body composition
  • Helps promote fat metabolism
  • Supports metabolic and wellness goals
  • Preserves the body's natural hormone pathways

Potential Benefits

  • Supports abdominal fat reduction
  • Promotes a leaner body composition
  • Supports energy and recovery
  • Promotes healthy metabolic function
  • Supports wellbeing

For research & education only. Suitability is confirmed by our care team after consultation.